Skip to main content

Advertisement

Log in

The antiviral activity of tumour necrosis factor on herpes simplex virus type 1: role for a butylated hydroxyanisole sensitive factor

  • Original Papers
  • Published:
Archives of Virology Aims and scope Submit manuscript

Summary

We have previously shown that specific antibodies (Mab 32/Ab 301) against tumour necrosis factor (TNF) enhance its antiviral activity in vaccinia virus-infected mice. In the present study, TNF alone was found to have antiviral activity against herpes simplex virus-1 (HSV-1). Antibody enhancement was found, both in vivo and in vitro, at lower TNF doses. The magnitude of the TNF-induced antiviral response was dependent upon the genetic background of the mouse. C57BL/6 mice were very sensitive to the antiviral activity of TNF, which was inhibited by the free radical scavenger butylated hydroxyanisole (BHA). TNF plus Mab 32 induced a significant antiviral effect in L929 cells which was associated with pronounced CPE. The CPE was largely reversed in the presence of BHA, and furthermore, TNF antiviral activity was significantly reversed in the presence of BHA. Specific inhibitors of nitric oxide synthetase, lipoxygenase or cyclo-oxygenase did not influence either the CPE or growth kinetics of HSV-1, suggesting that neither reactive nitrogen intermediates nor arachidonic acid metabolites were involved in the antiviral mechanism of TNF. This, together with observed increases in Cu/Zn SOD levels in virus infected cells, suggests that reactive oxygen intermediates may have a role in the direct control of HSV-1 growth and that free radicals may play a part in the antiviral activity induced by TNF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Akaike T, Ando M, Oda T, Doi T, Ijiri S, Araki S, Maeda H (1990) Dependence on O2-generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J Clin Invest 85: 739–745

    Google Scholar 

  2. Berkowitz C, Becker Y (1992) Recombinant interleukin-1α, interleukin-2 and M-CSF-1 enhance the survival of newborn C57BL/6 mice inoculated intraperitoneally with a lethal dose of herpes simplex virus-1. Arch Virol 124: 83–93

    Google Scholar 

  3. Bhattacherjee P, Boughton-Smith NK, Follenfant RL, Garland LG, Higgs GA (1988) The effects of a novel series of selective inhibitors of arachidonate 5-lipooxygenase on anaphylactic and inflammatory responses. Ann NY Acad Sci 524: 307–320

    Google Scholar 

  4. Brekke OL, Shalaby MR, Sundan A, Espevik T, Bjerve KS (1992) Butylated hydroxyanisole specifically inhibits tumour necrosis factor-induced cytotoxicity and growth enhancement. Cytokine 4: 269–280

    Google Scholar 

  5. Chan WL, Ziltener HJ, Liew FY (1990) Interleukin-3 protects mice from acute herpes simplex virus infection. Immunology 71: 358–363

    Google Scholar 

  6. Cho Y-B, Furst G, Paik WK (1984) Preparation of NG-monoethyl-l-arginine. Anal Biochem 139: 377–382

    Google Scholar 

  7. Cowden WB, Lewis-Hughes PH, Clark IA (1985) Protection against alloxan-induced diabetes in mice by the free radical scavenger butylated hydroxyanisole. Biochem Pharmacol 34: 3601–3603

    Google Scholar 

  8. Ding AH, Nathan CF, Stuehr DJ (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J Immunol 141: 2407–2412

    Google Scholar 

  9. Field HJ, Bell SE, Elion GB, Nash AA, Wildy P (1979) Effect of acycloguanosine treatment on acute and latent herpes simplex infections in mice. Antimicrob Agents Chemother 15: 554–561

    Google Scholar 

  10. Halliwell B, Gutteridge JMC, Cross CE (1992) Free radicals, antioxidants, and human disease: Where are we now? J Lab Clin Med 119: 598–620

    Google Scholar 

  11. Hendricks RL, Weber PC, Taylor JL, Koumbis A, Tumpey TM, Glorioso JC (1991) Endogenously produced interferon α protects mice from herpes simplex virus type 1 corneal disease. J Gen Virol 72: 1601–1610

    Google Scholar 

  12. Hill TJ, Yirrell DL, Blyth WA (1986) Infection of the adrenal gland as a route to the central nervous system after viraemia with herpes simplex virus in the mouse. J Gen Virol 67: 309–320

    Google Scholar 

  13. Huang TT, Carlson EJ, Epstein LB, Epstein CJ (1992) The role of superoxide anions in the establishment of an interferon-α-mediated antiviral state. Free Rad Res Comm 17: 59–72

    Google Scholar 

  14. Ikeda T, Shimokata K, Daikoku T, Fukatsu T, Tsutsui Y, Nishiyama Y (1992) Pathogenesis of cytomegalovirus-associated pneumonitis in ICR mice: possible involvement of superoxide radicals. Arch Virol 127: 11–24

    Google Scholar 

  15. Jacobsen H, Mestan J, Mittnacht S, Dieffenbach CW (1989) Beta interferon subtype 1 induction by tumour necrosis factor. Mol Cell Biol 9: 3037–3042

    Google Scholar 

  16. Koff WC, Fann AV (1986) Human tumor necrosis factor-alpha kills herpesvirus-infected but not normal cells. Lymphokine Res 5: 215–221

    Google Scholar 

  17. Lidbury BA, Aston R, Ramshaw IA, Cowden WB, Rathjen DA (1993) The enhancement of the in vivo antiviral efficacy of human tumour necrosis factor by monoclonal and specific polyclonal antibodies. Lymphokine Cytokine Res 12: 69–74

    Google Scholar 

  18. Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47: 469–474

    Google Scholar 

  19. Mestan J, Brockhaus M, Kirchner H, Jacobsen H (1988) Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2′,5′-adenylate synthetase. J Gen Virol 69: 3113–3120

    Google Scholar 

  20. Minami M, Yoshikawa H (1979) A simplified assay method of superoxide dismutase activity for clinical use. Clin Chim Acta 92: 337–342

    Google Scholar 

  21. Muller F (1992) Reactive oxygen intermediates and human immunodeficiency virus (HIV) infection. Free Rad Biol Med 13: 651–657

    Google Scholar 

  22. Munoz-Fernandez MA, Fernandez MA, Fresno M (1992) Synergism between tumour necrosis factor α and interferon gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur J Immunol 22: 301–307

    Google Scholar 

  23. Nacy CA, Nelson BJ, Meltzer MS, Green SJ (1991) Cytokines that regulate macrophage production of nitrogen oxides and expression of antileishmanial activities. Res Immunol 142: 573–576

    Google Scholar 

  24. Potratz D, Brake B, Dienes HP, Schulz THF, Hosp M, Dierich MP, Falke D (1986) Herpes simplex virus type 1 and 2 in the adrenal glands: replication and histopathology. Arch Virol 90: 207–222

    Google Scholar 

  25. Pottathil R, Chandrabose KA, Cuatrecasas P, Lang DJ (1981) Establishment of the interferon-mediated antiviral state: possible role of superoxide dismutase. Proc Natl Acad Sci USA 78: 3343–3347

    Google Scholar 

  26. Rathjen DA, Aston R (1993) Selective enhancement of tumour necrosis factor activity: mapping regions with monoclonal antibodies. Bioinorg Med Chem Lett 3: 457–462

    Google Scholar 

  27. Rathjen DA, Cowan K, Furphy LJ, Aston R (1991) Antigenic structure of human tumour necrosis factor: recognition of distinct regions of TNF a by different tumour cell receptors. Mol Immunol 28: 79–86

    Google Scholar 

  28. Rockett KA, Awburn MM, Aggarwal BB, Cowden WB, Clark IA (1992) In vivo induction of nitrite and nitrate by tumour necrosis factor, lymphotoxin, and interleukin-1: possible roles in malaria. Infect Immun 60: 3725–3730

    Google Scholar 

  29. Rossol-Voth R, Rossol S, Schutt KH, Corridori S, De Cian W, Falke D (1991) In vivo protective effect of tumour necrosis factor α against experimental infection with herpes simplex virus type 1. J Gen Virol 72: 143–147

    Google Scholar 

  30. Schewe T, Kuhn H, Rapoport SM (1987) Lipoxygenases: measurement, characterization and properties. In: Bendetto C, McDonald-Gibson RG, Nigam S, Slater TF (eds) Prostaglandins and related substances; a practical approach. IRL Press, Oxford, pp 229–242

    Google Scholar 

  31. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W (1992) Cytotoxic activity of tumour necrosis factor is mediated by early damage of mitochondrial functions. J Biol Chem 267: 5317–5323

    Google Scholar 

  32. Sienko S, Eis-Hubinger AM, Schneweis KE (1991) The role of free radical scavengers, inhibitors of prostaglandin synthesis, and hypomethylating agents in reactivation of latent herpes simplex virus. Med Microbiol Immunol 180: 249–259

    Google Scholar 

  33. Stanton GJ, Jordan C, Hart A, Heard H, Langford MP, Baron S (1987) Nondetectable levels of interferon gamma is a critical host defense during the first day of herpes simplex virus infection. Microbiol Pathol 3: 179–183

    Google Scholar 

  34. Wong GHW, Goeddel DV (1986) Tumour necrosis factors α and β inhibit virus replication and synergize with interferons. Nature 323: 819–822

    Google Scholar 

  35. Zawatzky R, Hilfenhaus J, Marcucci F, Kirchner H (1981) Experimental infection of inbred mice with herpes simplex virus type 1. I Investigation of humoral and cellular immunity and of interferon induction. J Gen Virol 53: 31–38

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lidbury, B.A., Ramshaw, I.A., Rolph, M.S. et al. The antiviral activity of tumour necrosis factor on herpes simplex virus type 1: role for a butylated hydroxyanisole sensitive factor. Archives of Virology 140, 703–719 (1995). https://doi.org/10.1007/BF01309959

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01309959

Keywords

Navigation